Abstract

Iron overload disorder (IOD) in critically endangered Sumatran (Dicerorhinus sumatrensis) and black (Diceros bicornis) rhinoceros is an over-accumulation of iron in organs which may exacerbate other diseases and indicate metabolic disturbances. IOD in rhinos is not well understood and diagnostics and therapeutics are limited in effectiveness. MicroRNAs (miRNAs) are small non-coding RNAs capable of altering protein synthesis. miRNA expression responds to physiological states and could serve as the basis for development of diagnostics and therapeutics. This study aimed to identify miRNAs differentially expressed among healthy rhinos and those afflicted with IOD or other diseases (“unhealthy”), and assess expression of select miRNAs to evaluate their potential as biomarkers of IOD. miRNAs in serum of black (n = 11 samples; five individuals) and Sumatran (n = 7 samples; four individuals) rhinos, representing individuals categorized as healthy (n = 9), unhealthy (n = 5), and afflicted by IOD (n = 3) were sequenced. In total, 715 miRNAs were identified, of which 160 were novel, 131 were specific to black rhinos, and 108 were specific to Sumatran rhinos. Additionally, 95 miRNAs were specific to healthy individuals, 31 specific to unhealthy, and 63 were specific to IOD individuals. Among healthy, unhealthy, and IOD states, 21 miRNAs were differentially expressed (P ≤ 0.01). Five known miRNAs (let-7g, miR-16b, miR-30e, miR-143, and miR-146a) were selected for further assessment via RT-qPCR in serum from black (n = 61 samples; seven individuals) and Sumatran (n = 38 samples; five individuals) rhinos. let-7g, miR-30e, and miR-143 all showed significant increased expression (P ≤ 0.05) during IOD (between 1 and 2 years prior to death) and late IOD (within 1 year of death) compared to healthy and unhealthy individuals. miR-16b expression increased (P ≤ 0.05) in late IOD, but was not different among IOD, healthy, and unhealthy states (P > 0.05). Expression of miR-146a increased in IOD and late IOD as compared to unhealthy samples (P ≤ 0.05) but was not different from the healthy state (P > 0.05). Selected serum miRNAs of black and Sumatran rhinos, in particular let-7g, miR-30e, and miR-143, could therefore provide a tool for advancing rhino IOD diagnostics that should be further investigated.

Highlights

  • The survival of all five extant species of rhinoceros is threatened due to several challenges, including poaching and habitat loss

  • The main goals of this study were to [1] identify miRNAs differentially expressed between healthy rhinos and those known to be afflicted with Iron overload disorder (IOD) or other diseases, and [2] assess longitudinal expression of select miRNAs to evaulate their potential as IOD biomarkers

  • Nine samples from healthy black (n = 5) and Sumatran (n = 4) rhinos were compared to four samples collected from IOD animals (n = 3 individuals; one black rhino, two Sumatran rhinos) and five samples collected from unhealthy individuals known to be diagnosed with another disease including cancer, arthritis, and hypercalcemia

Read more

Summary

Introduction

The survival of all five extant species of rhinoceros ( referred to as “rhinos”) is threatened due to several challenges, including poaching and habitat loss. Some populations are experiencing an increase in numbers, the global rhino population has recently been in decline. Four of the species (black (Diceros bicornis), greater one-horned (GOH; Rhinoceros unicornis), Sumatran (Dicerorhinus sumatrensis), and white (Ceratotherium simum) rhinos) are managed in ex situ populations which may provide insurance against species extinction. Maintaining genetically sound and sustainable populations is not without challenges. Experience in animal husbandry and advances in veterinary care have led to improved longevity and productivity for intensively managed rhinos. Certain diseases, seemingly unique to individuals in human care, impact overall population well-being

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call